Opiant Pharmaceuticals Issues Statement in Response to Fake Press Release

SANTA MONICA, Calif., April 29, 2022 /PRNewswire/ -- Opiant Pharmaceuticals (NASDAQ: OPNT) was the subject of a fake news release issued on Friday, April 29, 2022, that falsely stated Opiant announced a partnership with Hikma Pharmaceuticals, PLC. Opiant had no knowledge of the press...

Click to view original post